Hybrid Assembly – (ii): The Error Models of PacBio Reads
Now that we have contigs assembled from short Illumina reads aligned on to long PacBio reads, the question of which one to trust often pops us in our mind. Let us explain the issues more clearly.
——————————————————————–
A. Often we come across regions, where 3/4th of a long Illumina contig matches very well with the PacBio read (after allowing for 85% of error rate), but the remaining contig is not seen anywhere nearby.
Possibilities:
Illumina is correct.
One can make a case that Illumina contig is built from hundreds of short overlapping regions, and therefore the Illumina contig is more accurate.
PacBio is correct.
One can also argue that the particular genomic region is different in two chromosomes and the PacBio read is capturing a different chromosome compared to what is assembled from Illumina. Possibly the chromosomal region has a large insertion/deletion.
——————————————————————–
B. We also come across regions, where the Illumina contig matches PacBio closely, but has a large gap inside. The gap is usually filled with homopolymers.
Possibilities:
Once again, one can argue about both possibilities mentioned in A.
——————————————————————–
C. Third case of ambiguity is multiple copies of the same Illumina contigs matching a PacBio contig.
Possibilities:
PacBio is correct.
By its design, k-mer based de Bruijn graph assembly compresses duplicated regions into one block. Therefore, the contig assembly method used for Illumina reads is incapable of resolving tandem repeat regions.
Illumina is correct.
PacBio technology circularizes the chromosomal fragments and then goes over them again and again. Therefore, the raw PacBio reads have multiple copies of the same chromosomal region, but the initial processing step splits them into different reads. It is possible that the processing step may have missed a few circularized junctions.
—————————————————————–
Yesterday, we took time to meticulously work through a few cases to understand what is going on, and we will share the examples here. They are anecdotal cases rather than systematic analysis of the entire data set, but will illustrate the points mentioned in A, B and C to help you appreciate the issues.
This commentary will be expanded with many figures and examples.
http://www.homolog.us/blogs/blog/2014/02/12/hybrid-assembly-ii-error-models-pacbio-reads/- (Bobby Sebra's #AGBT14 poster: an all-in-one Infectious Disease Pipeline using @PacBio long reads Thursday 1:00-2:30 pic.twitter.com/2qTCXwEU2g)-https://twitter.com/IcahnInstitute/status/433706208562647040/photo/1
Recent PACB News
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:17:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:07:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:17:12 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM